Cargando…

Metaplastic Carcinoma with Extensive Chondroid Differentiation in the Breast (Chondroid Carcinoma)

Metaplastic breast carcinoma is very rare, and metaplastic carcinoma with chondroid differentiation is even rarer. Here, we report a case of metaplastic carcinoma with extensive chondroid differentiation mimicking chondrosarcoma that was challenging to diagnose. The tumor was characterized by an abu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yee-Jeong, Shim, Hyo-Seob, Lee, Hyde, Jung, Woo-Hee
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687638/
https://www.ncbi.nlm.nih.gov/pubmed/16642558
http://dx.doi.org/10.3349/ymj.2006.47.2.259
_version_ 1782167558320816128
author Kim, Yee-Jeong
Shim, Hyo-Seob
Lee, Hyde
Jung, Woo-Hee
author_facet Kim, Yee-Jeong
Shim, Hyo-Seob
Lee, Hyde
Jung, Woo-Hee
author_sort Kim, Yee-Jeong
collection PubMed
description Metaplastic breast carcinoma is very rare, and metaplastic carcinoma with chondroid differentiation is even rarer. Here, we report a case of metaplastic carcinoma with extensive chondroid differentiation mimicking chondrosarcoma that was challenging to diagnose. The tumor was characterized by an abundant chondromyxoid matrix. The definitive area of classic invasive ductal carcinoma was minimal. The peripheral portion of the tumor showed increased cellularity with pleomorphism and definitive invasive growth. Tumor cells in the chondrosarcomatous areas were diffusely immunoreactive for S-100 protein, patchy positive for cytokeratin, but negative for epithelial membrane antigen (EMA). Tumor cells in carcinomatous areas were diffusely positive for cytokeratin, S-100 protein, and patchy positive for EMA. In both areas, tumor cells were negative for smooth muscle actin (SMA) and CD34, while oncoprotein p53 was overexpressed. When pathologists encounter breast tumors with chondroid differentiation, careful sampling and immunohistochemistry for cytokeratin and SMA are most helpful to differentiate metaplastic carcinoma from malignant phyllodes tumor and malignant adenomyoepithelioma.
format Text
id pubmed-2687638
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-26876382009-06-04 Metaplastic Carcinoma with Extensive Chondroid Differentiation in the Breast (Chondroid Carcinoma) Kim, Yee-Jeong Shim, Hyo-Seob Lee, Hyde Jung, Woo-Hee Yonsei Med J Case Report Metaplastic breast carcinoma is very rare, and metaplastic carcinoma with chondroid differentiation is even rarer. Here, we report a case of metaplastic carcinoma with extensive chondroid differentiation mimicking chondrosarcoma that was challenging to diagnose. The tumor was characterized by an abundant chondromyxoid matrix. The definitive area of classic invasive ductal carcinoma was minimal. The peripheral portion of the tumor showed increased cellularity with pleomorphism and definitive invasive growth. Tumor cells in the chondrosarcomatous areas were diffusely immunoreactive for S-100 protein, patchy positive for cytokeratin, but negative for epithelial membrane antigen (EMA). Tumor cells in carcinomatous areas were diffusely positive for cytokeratin, S-100 protein, and patchy positive for EMA. In both areas, tumor cells were negative for smooth muscle actin (SMA) and CD34, while oncoprotein p53 was overexpressed. When pathologists encounter breast tumors with chondroid differentiation, careful sampling and immunohistochemistry for cytokeratin and SMA are most helpful to differentiate metaplastic carcinoma from malignant phyllodes tumor and malignant adenomyoepithelioma. Yonsei University College of Medicine 2006-04-30 2006-04-30 /pmc/articles/PMC2687638/ /pubmed/16642558 http://dx.doi.org/10.3349/ymj.2006.47.2.259 Text en Copyright © 2006 The Yonsei University College of Medicine http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kim, Yee-Jeong
Shim, Hyo-Seob
Lee, Hyde
Jung, Woo-Hee
Metaplastic Carcinoma with Extensive Chondroid Differentiation in the Breast (Chondroid Carcinoma)
title Metaplastic Carcinoma with Extensive Chondroid Differentiation in the Breast (Chondroid Carcinoma)
title_full Metaplastic Carcinoma with Extensive Chondroid Differentiation in the Breast (Chondroid Carcinoma)
title_fullStr Metaplastic Carcinoma with Extensive Chondroid Differentiation in the Breast (Chondroid Carcinoma)
title_full_unstemmed Metaplastic Carcinoma with Extensive Chondroid Differentiation in the Breast (Chondroid Carcinoma)
title_short Metaplastic Carcinoma with Extensive Chondroid Differentiation in the Breast (Chondroid Carcinoma)
title_sort metaplastic carcinoma with extensive chondroid differentiation in the breast (chondroid carcinoma)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687638/
https://www.ncbi.nlm.nih.gov/pubmed/16642558
http://dx.doi.org/10.3349/ymj.2006.47.2.259
work_keys_str_mv AT kimyeejeong metaplasticcarcinomawithextensivechondroiddifferentiationinthebreastchondroidcarcinoma
AT shimhyoseob metaplasticcarcinomawithextensivechondroiddifferentiationinthebreastchondroidcarcinoma
AT leehyde metaplasticcarcinomawithextensivechondroiddifferentiationinthebreastchondroidcarcinoma
AT jungwoohee metaplasticcarcinomawithextensivechondroiddifferentiationinthebreastchondroidcarcinoma